Consensus Masimo Corporation

Equities

MASI

US5747951003

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX Other stock markets 12:32:32 2025-12-16 pm EST			5-day change	1st Jan Change
133.32 ^USD	-2.97%		-3.46%	-19.04%

Dec. 03	Masimo Outlines Long-Term Targets, Reaffirms 2025 Guidance	MT
Dec. 04	Masimo Corporation - Analyst/Investor Day

Evolution of the Average Target: Masimo Corporation

Evolution of the Target Price: Masimo Corporation

Changes in Analyst Recommendations: Masimo Corporation

ff19f5f7a5ae3f205c48fdb.dm70jAUpDEUb0vwb-0G32LQ4Sb8dL2kQrOpHiPZPniw.LFej_kplOAlI4rVzsXfgqcV3PMhKbDpm3IUu68d8p30fW7_DfX1qdXzgxA~6b584782be7a9f1251f6c0541f82f50f

Analysts' recommendations: Masimo Corporation

Nov. 17	BofA Securities Initiates Masimo at Neutral With $162 Price Target	MT
Nov. 17	Data Drought Breaks and Markets Brace for the Flood
Sep. 17	Masimo Corporation Announces Findings of Cost-Savings Study Demonstrating Operational Effectiveness of Continuous Patient Monitoring Technologies	CI
Aug. 21	The Bubble Flickers
Nov. 06	Analyst recommendations: Snap, Qualys, Sirius XM, Super Micro Computer, Burberry...
24-10-16	Analyst recommendations: Cisco, 3M Company, Rivian, United AIrlines, Moonpig...
24-09-20	Masimo May Face Short-term Challenges Following Possible CEO Change, Needham Says	MT
24-07-15	ISS recommends Masimo investors elect activist Politan candidates to board	RE
24-07-11	Masimo Urges Shareholders to Support Director Nominees	MT
24-07-04	Analyst recommendations: Citigroup, Constellation Brands, Broadcom, JPMorgan, Bunzl...
24-06-17	Masimo Corporation Files Definitive Proxy Statement with Securities and Exchange Commission	CI
24-06-03	Piper Sandler Upgrades Masimo to Overweight, Price Target at $160	MT
24-05-31	Masimo's Third Settlement Offer Rejected by Politan Capital Management	MT
24-04-15	Stifel Upgrades Masimo to Buy From Hold, Raises Price Target to $170 From $148	MT
24-04-08	Apple to Allow Other Payment Options for Music Apps in Europe; Appeals to Overturn Apple Watch Import Ban	MT
24-03-25	Stifel Adjusts Price Target on Masimo to $148 From $125, Maintains Hold Rating	MT
24-03-25	BTIG Raises Price Target on Masimo to $166 From $145, Maintains Buy Rating	MT
24-03-25	Wells Fargo Upgrades Masimo to Overweight From Equalweight, Adjusts Price Target to $160 From $117	MT
24-02-26	Piper Sandler Adjusts Masimo Price Target to $117 From $70, Maintains Neutral Rating	MT
24-01-30	Jefferies Downgrades Masimo to Hold From Buy, Raises Price Target to $121 From $107	MT
24-01-03	Needham Downgrades Masimo to Hold From Buy	MT
23-11-08	Wells Fargo Adjusts Price Target on Masimo to $81 From $110, Maintains Equal-Weight Rating	MT
23-11-08	Raymond James Downgrades Masimo to Market Perform From Outperform	MT
23-11-08	Needham Adjusts Price Target on Masimo to $86 From $136, Maintains Buy Rating	MT
23-08-10	Raymond James Adjusts Price Target on Masimo to $142 From $198, Keeps Outperform Rating	MT

More recommendations

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
MASIMO CORPORATION			+33.73%
PENUMBRA, INC.			+0.98%
GETINGE AB			+10.18%
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.			+33.05%
ASAHI INTECC CO., LTD.			+12.27%
APT MEDICAL INC.			+51.56%
INARI MEDICAL, INC.	-	-	-
CHEMOMETEC A/S			+26.73%
Average			+24.07%
Weighted average by Cap.			+20.03%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

137.40USD

Average target price

183.75USD

Spread / Average Target

+33.73%

High Price Target

210.00USD

Spread / Highest target

+52.84%

Low Price Target

162.00USD

Spread / Lowest Target

+17.90%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

BofA Securities
Piper Sandler
Stifel Nicolaus
Wells Fargo Securities
BTIG
Jefferies & Co.
Needham & Co.
Raymond James
Wolfe Research
Loop Capital
Tudor Pickering Holt & Co.
UBS
Berenberg Bank